214 related articles for article (PubMed ID: 33241425)
1. Melanoma Risk is Increased in Patients with Mycosis Fungoides Compared with Patients with Psoriasis and the General Population.
Sherman S; Kremer N; Dalal A; Solomon-Cohen E; Berkovich E; Noyman Y; Ben-Lassan M; Levi A; Pavlovsky L; Prag Naveh H; Hodak E; Amitay-Laish I
Acta Derm Venereol; 2020 Dec; 100(19):adv00346. PubMed ID: 33241425
[TBL] [Abstract][Full Text] [Related]
2. Risk of mycosis fungoides in psoriatic patients: a critical review.
Biondo G; Cerroni L; Brunasso AMG; Sola S; Cota C; Javor S; Massone C
J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1186-1195. PubMed ID: 31856345
[TBL] [Abstract][Full Text] [Related]
3. Mycosis fungoides associated with malignant melanoma and dysplastic nevus syndrome.
Pielop JA; Brownell I; Duvic M
Int J Dermatol; 2003 Feb; 42(2):116-22. PubMed ID: 12708999
[TBL] [Abstract][Full Text] [Related]
4. Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real-life experience from a single tertiary center.
Doğan PE; Akay BN; Vural S; Arı C; Yılmaz TE; Şanlı H
Photodermatol Photoimmunol Photomed; 2023 Sep; 39(5):428-434. PubMed ID: 36967646
[TBL] [Abstract][Full Text] [Related]
5. Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma.
Goyal A; O'Leary D; Goyal K; Rubin N; Janakiram M
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1821-1829. PubMed ID: 34013554
[TBL] [Abstract][Full Text] [Related]
6. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
[TBL] [Abstract][Full Text] [Related]
9. The different faces of mycosis fungoides: results of a single-center study.
Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and prognostic factors of 114 patients with mycosis fungoides in a Moroccan cohort: a 29-year review.
Titou H; Bouhamidi A
Clin Exp Med; 2023 Nov; 23(7):3751-3758. PubMed ID: 37029872
[TBL] [Abstract][Full Text] [Related]
11. Phototherapy for mycosis fungoides.
Dogra S; Mahajan R
Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
[TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management.
Kothari R; Szepietowski JC; Bagot M; Sandhu S; Patil A; Grabbe S; Goldust M
Int J Dermatol; 2022 Dec; 61(12):1458-1466. PubMed ID: 35193164
[TBL] [Abstract][Full Text] [Related]
13. The head and neck manifestations of mycosis fungoides.
Brennan JA
Laryngoscope; 1995 May; 105(5 Pt 1):478-80. PubMed ID: 7760661
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium.
Olsen EA; Hodak E; Anderson T; Carter JB; Henderson M; Cooper K; Lim HW
J Am Acad Dermatol; 2016 Jan; 74(1):27-58. PubMed ID: 26547257
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
[TBL] [Abstract][Full Text] [Related]
16. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
17. Psoriasiform mycosis fungoides: a rare form of the disease with review of the literature.
Azizpour A; Ghanadan A; Nasimi M; Etesami I
Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469726
[TBL] [Abstract][Full Text] [Related]
18. Hyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides.
Jung JM; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
Leuk Lymphoma; 2022 Jul; 63(7):1598-1606. PubMed ID: 35201905
[TBL] [Abstract][Full Text] [Related]
19. Mycosis Fungoides in Puerto Rico: A 15-year Follow-up Retrospective Study.
Arias-Berrios GE; Falto-Aizpurua L; Figueroa-Guzmán L
P R Health Sci J; 2020 Dec; 39(4):306-310. PubMed ID: 33320459
[TBL] [Abstract][Full Text] [Related]
20. Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management.
Wu JH; Cohen BA; Sweren RJ
Pediatr Dermatol; 2020 Jan; 37(1):18-28. PubMed ID: 31630432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
